

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sequestering of actin monomers (GO:0042989) | 9.52836251 |
| 2 | histone H4-K12 acetylation (GO:0043983) | 7.65284140 |
| 3 | negative regulation of execution phase of apoptosis (GO:1900118) | 5.83317051 |
| 4 | positive regulation of action potential (GO:0045760) | 5.80683508 |
| 5 | lens morphogenesis in camera-type eye (GO:0002089) | 5.51380299 |
| 6 | cell junction maintenance (GO:0034331) | 5.44934966 |
| 7 | regulation of cell communication by electrical coupling (GO:0010649) | 5.24949778 |
| 8 | cell-cell junction maintenance (GO:0045217) | 5.09747473 |
| 9 | dopamine biosynthetic process (GO:0042416) | 4.92619889 |
| 10 | response to insecticide (GO:0017085) | 4.90950584 |
| 11 | alternative mRNA splicing, via spliceosome (GO:0000380) | 4.74348089 |
| 12 | dopaminergic neuron differentiation (GO:0071542) | 4.65872174 |
| 13 | regulation of action potential (GO:0098900) | 4.63475044 |
| 14 | regulation of acrosome reaction (GO:0060046) | 4.42916663 |
| 15 | fusion of sperm to egg plasma membrane (GO:0007342) | 4.42686497 |
| 16 | rRNA methylation (GO:0031167) | 4.41739848 |
| 17 | neuronal action potential (GO:0019228) | 4.36510078 |
| 18 | regulation of energy homeostasis (GO:2000505) | 4.25933298 |
| 19 | apical protein localization (GO:0045176) | 4.08523363 |
| 20 | negative regulation of activin receptor signaling pathway (GO:0032926) | 4.01978111 |
| 21 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 4.00500595 |
| 22 | neural tube formation (GO:0001841) | 3.95667264 |
| 23 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.85560912 |
| 24 | sperm capacitation (GO:0048240) | 3.83724838 |
| 25 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.79490631 |
| 26 | catechol-containing compound biosynthetic process (GO:0009713) | 3.74421922 |
| 27 | catecholamine biosynthetic process (GO:0042423) | 3.74421922 |
| 28 | ear development (GO:0043583) | 3.72693629 |
| 29 | negative regulation of gene silencing (GO:0060969) | 3.65330652 |
| 30 | embryonic body morphogenesis (GO:0010172) | 3.64855850 |
| 31 | spinal cord motor neuron differentiation (GO:0021522) | 3.58370589 |
| 32 | protein polyglutamylation (GO:0018095) | 3.56178808 |
| 33 | cellular response to nicotine (GO:0071316) | 3.55905382 |
| 34 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.54861765 |
| 35 | negative regulation of meiosis (GO:0045835) | 3.51184703 |
| 36 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.49617069 |
| 37 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 3.43337968 |
| 38 | regulation of hexokinase activity (GO:1903299) | 3.41256114 |
| 39 | regulation of glucokinase activity (GO:0033131) | 3.41256114 |
| 40 | rRNA modification (GO:0000154) | 3.38904112 |
| 41 | epithelial cell differentiation involved in kidney development (GO:0035850) | 3.36903501 |
| 42 | embryonic epithelial tube formation (GO:0001838) | 3.35528750 |
| 43 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.32402857 |
| 44 | plasma membrane fusion (GO:0045026) | 3.30056374 |
| 45 | positive regulation of protein targeting to membrane (GO:0090314) | 3.25395662 |
| 46 | hindbrain development (GO:0030902) | 3.22632967 |
| 47 | epithelial tube formation (GO:0072175) | 3.21542922 |
| 48 | regulation of execution phase of apoptosis (GO:1900117) | 3.21063329 |
| 49 | negative regulation of meiotic cell cycle (GO:0051447) | 3.20478250 |
| 50 | serotonin metabolic process (GO:0042428) | 3.19040497 |
| 51 | DNA deamination (GO:0045006) | 3.18607569 |
| 52 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 3.16366359 |
| 53 | negative regulation of telomere maintenance (GO:0032205) | 3.15690266 |
| 54 | action potential (GO:0001508) | 3.07983493 |
| 55 | metanephric mesenchyme development (GO:0072075) | 3.07939118 |
| 56 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.06953734 |
| 57 | cytidine metabolic process (GO:0046087) | 3.04011022 |
| 58 | cytidine catabolic process (GO:0006216) | 3.04011022 |
| 59 | cytidine deamination (GO:0009972) | 3.04011022 |
| 60 | glomerulus development (GO:0032835) | 3.00837073 |
| 61 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.99351972 |
| 62 | camera-type eye morphogenesis (GO:0048593) | 2.98100517 |
| 63 | neuron maturation (GO:0042551) | 2.97733460 |
| 64 | body morphogenesis (GO:0010171) | 2.96717668 |
| 65 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.95854024 |
| 66 | thrombin receptor signaling pathway (GO:0070493) | 2.92441022 |
| 67 | regulation of gene silencing by RNA (GO:0060966) | 2.92366676 |
| 68 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.92366676 |
| 69 | regulation of gene silencing by miRNA (GO:0060964) | 2.92366676 |
| 70 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.91257180 |
| 71 | negative regulation of catenin import into nucleus (GO:0035414) | 2.90001843 |
| 72 | epithelial cilium movement (GO:0003351) | 2.89860439 |
| 73 | piRNA metabolic process (GO:0034587) | 2.87378041 |
| 74 | postsynaptic membrane organization (GO:0001941) | 2.86564106 |
| 75 | midbrain development (GO:0030901) | 2.84949704 |
| 76 | oligosaccharide biosynthetic process (GO:0009312) | 2.84496309 |
| 77 | T-helper cell differentiation (GO:0042093) | 2.83247833 |
| 78 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.83247833 |
| 79 | drug catabolic process (GO:0042737) | 2.82871172 |
| 80 | lymphoid progenitor cell differentiation (GO:0002320) | 2.81259102 |
| 81 | microtubule severing (GO:0051013) | 2.81167503 |
| 82 | galactose catabolic process (GO:0019388) | 2.80386715 |
| 83 | peptidyl-histidine modification (GO:0018202) | 2.79454321 |
| 84 | primary amino compound metabolic process (GO:1901160) | 2.75950933 |
| 85 | histone H4-K5 acetylation (GO:0043981) | 2.74487030 |
| 86 | histone H4-K8 acetylation (GO:0043982) | 2.74487030 |
| 87 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.71754492 |
| 88 | regulation of cilium movement (GO:0003352) | 2.70720156 |
| 89 | norepinephrine metabolic process (GO:0042415) | 2.69023104 |
| 90 | T cell differentiation involved in immune response (GO:0002292) | 2.69017195 |
| 91 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.69017195 |
| 92 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.69017195 |
| 93 | sympathetic nervous system development (GO:0048485) | 2.68446290 |
| 94 | nucleobase catabolic process (GO:0046113) | 2.66774438 |
| 95 | lens development in camera-type eye (GO:0002088) | 2.61369390 |
| 96 | G-protein coupled receptor internalization (GO:0002031) | 2.59595100 |
| 97 | positive regulation of gastrulation (GO:2000543) | 2.59217084 |
| 98 | kidney mesenchyme development (GO:0072074) | 2.56969435 |
| 99 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.56688359 |
| 100 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.56149850 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.93510611 |
| 2 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 5.49838694 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.94949118 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.80364993 |
| 5 | VDR_22108803_ChIP-Seq_LS180_Human | 3.50105445 |
| 6 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.97220132 |
| 7 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.93803238 |
| 8 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.74755568 |
| 9 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.60852663 |
| 10 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.54417334 |
| 11 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.52212618 |
| 12 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.10889686 |
| 13 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.08295918 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.07342427 |
| 15 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.05905041 |
| 16 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.05520716 |
| 17 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.99341007 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.94485369 |
| 19 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.89882362 |
| 20 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.86968941 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.85464829 |
| 22 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.77647844 |
| 23 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.72899667 |
| 24 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.71320646 |
| 25 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.62240334 |
| 26 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.61382466 |
| 27 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.61124091 |
| 28 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.55357627 |
| 29 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.54998585 |
| 30 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.52764376 |
| 31 | P300_19829295_ChIP-Seq_ESCs_Human | 1.51871534 |
| 32 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.51339601 |
| 33 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.49945655 |
| 34 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.48386497 |
| 35 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.47480836 |
| 36 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.45536176 |
| 37 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.45444783 |
| 38 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.45154559 |
| 39 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.42682891 |
| 40 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.42347217 |
| 41 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.39571316 |
| 42 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.34798166 |
| 43 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.33015687 |
| 44 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.33015687 |
| 45 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.32788156 |
| 46 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.31753135 |
| 47 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.30363505 |
| 48 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.27857908 |
| 49 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.25289269 |
| 50 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.24625643 |
| 51 | EWS_26573619_Chip-Seq_HEK293_Human | 1.20512266 |
| 52 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.19466058 |
| 53 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.16425794 |
| 54 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.15558039 |
| 55 | KDM2B_26808549_Chip-Seq_REH_Human | 1.15146113 |
| 56 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.14820104 |
| 57 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.14510053 |
| 58 | RXR_22108803_ChIP-Seq_LS180_Human | 1.13704251 |
| 59 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.12103704 |
| 60 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.08956058 |
| 61 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.07987055 |
| 62 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.07073243 |
| 63 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.06610264 |
| 64 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.06046688 |
| 65 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.05952201 |
| 66 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.05735740 |
| 67 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.03411811 |
| 68 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.02162194 |
| 69 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.01606326 |
| 70 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.99617865 |
| 71 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.99370565 |
| 72 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.99357473 |
| 73 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.97550401 |
| 74 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.96106497 |
| 75 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.95895210 |
| 76 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.95437712 |
| 77 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.94956624 |
| 78 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.94273212 |
| 79 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.94262330 |
| 80 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94157273 |
| 81 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.93878488 |
| 82 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.92912319 |
| 83 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92491807 |
| 84 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.91891452 |
| 85 | FUS_26573619_Chip-Seq_HEK293_Human | 0.90443973 |
| 86 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.88265886 |
| 87 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88262610 |
| 88 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.87416632 |
| 89 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.85911672 |
| 90 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85555119 |
| 91 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.83655479 |
| 92 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.82487322 |
| 93 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.82107461 |
| 94 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.81767942 |
| 95 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.81494034 |
| 96 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.81099012 |
| 97 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.81099012 |
| 98 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.80656065 |
| 99 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.80227230 |
| 100 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.79494175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 6.82260434 |
| 2 | MP0009379_abnormal_foot_pigmentation | 6.66288129 |
| 3 | MP0003880_abnormal_central_pattern | 3.51600179 |
| 4 | MP0002277_abnormal_respiratory_mucosa | 3.31673042 |
| 5 | MP0002736_abnormal_nociception_after | 3.08429409 |
| 6 | MP0003283_abnormal_digestive_organ | 3.07672126 |
| 7 | MP0005174_abnormal_tail_pigmentation | 2.94159681 |
| 8 | MP0000015_abnormal_ear_pigmentation | 2.93185597 |
| 9 | MP0003011_delayed_dark_adaptation | 2.80629014 |
| 10 | MP0003646_muscle_fatigue | 2.69729075 |
| 11 | MP0001905_abnormal_dopamine_level | 2.68527056 |
| 12 | MP0000372_irregular_coat_pigmentation | 2.55819238 |
| 13 | MP0008789_abnormal_olfactory_epithelium | 2.25322644 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.12224289 |
| 15 | MP0001873_stomach_inflammation | 1.83138063 |
| 16 | MP0004133_heterotaxia | 1.81032317 |
| 17 | MP0001986_abnormal_taste_sensitivity | 1.75696243 |
| 18 | MP0000534_abnormal_ureter_morphology | 1.75320042 |
| 19 | MP0002184_abnormal_innervation | 1.74383852 |
| 20 | MP0002638_abnormal_pupillary_reflex | 1.64301191 |
| 21 | MP0001188_hyperpigmentation | 1.62307110 |
| 22 | MP0002095_abnormal_skin_pigmentation | 1.62186214 |
| 23 | MP0005394_taste/olfaction_phenotype | 1.52702217 |
| 24 | MP0005499_abnormal_olfactory_system | 1.52702217 |
| 25 | MP0004130_abnormal_muscle_cell | 1.50804111 |
| 26 | MP0001485_abnormal_pinna_reflex | 1.38275735 |
| 27 | MP0003136_yellow_coat_color | 1.36972809 |
| 28 | MP0002751_abnormal_autonomic_nervous | 1.36231398 |
| 29 | MP0002876_abnormal_thyroid_physiology | 1.36210066 |
| 30 | MP0004270_analgesia | 1.35819249 |
| 31 | MP0003385_abnormal_body_wall | 1.30568634 |
| 32 | MP0005171_absent_coat_pigmentation | 1.25957230 |
| 33 | MP0002734_abnormal_mechanical_nocicepti | 1.24903084 |
| 34 | MP0000566_synostosis | 1.20736475 |
| 35 | MP0003252_abnormal_bile_duct | 1.20008157 |
| 36 | MP0009697_abnormal_copulation | 1.17478809 |
| 37 | MP0000778_abnormal_nervous_system | 1.17264924 |
| 38 | MP0005075_abnormal_melanosome_morpholog | 1.13861903 |
| 39 | MP0000427_abnormal_hair_cycle | 1.13104975 |
| 40 | MP0003632_abnormal_nervous_system | 1.12990129 |
| 41 | MP0009053_abnormal_anal_canal | 1.12159861 |
| 42 | MP0000462_abnormal_digestive_system | 1.11859289 |
| 43 | MP0005645_abnormal_hypothalamus_physiol | 1.11524851 |
| 44 | MP0009745_abnormal_behavioral_response | 1.10419509 |
| 45 | MP0000955_abnormal_spinal_cord | 1.08014176 |
| 46 | MP0001324_abnormal_eye_pigmentation | 1.04970896 |
| 47 | MP0000383_abnormal_hair_follicle | 1.04351529 |
| 48 | MP0002938_white_spotting | 1.04003126 |
| 49 | MP0001664_abnormal_digestion | 1.03989204 |
| 50 | MP0000467_abnormal_esophagus_morphology | 1.00047805 |
| 51 | MP0002102_abnormal_ear_morphology | 0.97434674 |
| 52 | MP0003942_abnormal_urinary_system | 0.96978274 |
| 53 | MP0002272_abnormal_nervous_system | 0.96166345 |
| 54 | MP0003950_abnormal_plasma_membrane | 0.95482715 |
| 55 | MP0002332_abnormal_exercise_endurance | 0.95460612 |
| 56 | MP0005409_darkened_coat_color | 0.94164145 |
| 57 | MP0002234_abnormal_pharynx_morphology | 0.94033603 |
| 58 | MP0003635_abnormal_synaptic_transmissio | 0.93782724 |
| 59 | MP0005266_abnormal_metabolism | 0.91941224 |
| 60 | MP0004145_abnormal_muscle_electrophysio | 0.91463807 |
| 61 | MP0003186_abnormal_redox_activity | 0.89627588 |
| 62 | MP0002064_seizures | 0.89299952 |
| 63 | MP0003959_abnormal_lean_body | 0.89242777 |
| 64 | MP0002067_abnormal_sensory_capabilities | 0.86909361 |
| 65 | MP0003119_abnormal_digestive_system | 0.85260154 |
| 66 | MP0002108_abnormal_muscle_morphology | 0.81378982 |
| 67 | MP0000049_abnormal_middle_ear | 0.81153730 |
| 68 | MP0005448_abnormal_energy_balance | 0.81076517 |
| 69 | MP0004883_abnormal_blood_vessel | 0.78925337 |
| 70 | MP0005503_abnormal_tendon_morphology | 0.78898581 |
| 71 | MP0003937_abnormal_limbs/digits/tail_de | 0.77877879 |
| 72 | MP0003195_calcinosis | 0.77664342 |
| 73 | MP0004142_abnormal_muscle_tone | 0.77025358 |
| 74 | MP0002233_abnormal_nose_morphology | 0.75390083 |
| 75 | MP0002127_abnormal_cardiovascular_syste | 0.74955304 |
| 76 | MP0000428_abnormal_craniofacial_morphol | 0.74614417 |
| 77 | MP0000470_abnormal_stomach_morphology | 0.74111737 |
| 78 | MP0006292_abnormal_olfactory_placode | 0.73637809 |
| 79 | MP0002282_abnormal_trachea_morphology | 0.72843938 |
| 80 | MP0000465_gastrointestinal_hemorrhage | 0.71913209 |
| 81 | MP0003315_abnormal_perineum_morphology | 0.68814760 |
| 82 | MP0005423_abnormal_somatic_nervous | 0.68543270 |
| 83 | MP0002653_abnormal_ependyma_morphology | 0.67739401 |
| 84 | MP0003936_abnormal_reproductive_system | 0.66577731 |
| 85 | MP0004811_abnormal_neuron_physiology | 0.64878630 |
| 86 | MP0005085_abnormal_gallbladder_physiolo | 0.64736008 |
| 87 | MP0006276_abnormal_autonomic_nervous | 0.62512015 |
| 88 | MP0000631_abnormal_neuroendocrine_gland | 0.62093395 |
| 89 | MP0008995_early_reproductive_senescence | 0.61531109 |
| 90 | MP0005083_abnormal_biliary_tract | 0.59539013 |
| 91 | MP0003938_abnormal_ear_development | 0.59309381 |
| 92 | MP0002928_abnormal_bile_duct | 0.58605586 |
| 93 | MP0003638_abnormal_response/metabolism_ | 0.58241974 |
| 94 | MP0002177_abnormal_outer_ear | 0.57016716 |
| 95 | MP0003943_abnormal_hepatobiliary_system | 0.56420136 |
| 96 | MP0002882_abnormal_neuron_morphology | 0.55277279 |
| 97 | MP0003137_abnormal_impulse_conducting | 0.54278065 |
| 98 | MP0001765_abnormal_ion_homeostasis | 0.51789204 |
| 99 | MP0008961_abnormal_basal_metabolism | 0.50681476 |
| 100 | MP0000639_abnormal_adrenal_gland | 0.49550118 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 6.99437102 |
| 2 | Parakeratosis (HP:0001036) | 6.38211361 |
| 3 | Chronic bronchitis (HP:0004469) | 4.56538571 |
| 4 | Acanthocytosis (HP:0001927) | 4.44379014 |
| 5 | Maternal diabetes (HP:0009800) | 4.09627129 |
| 6 | Congenital, generalized hypertrichosis (HP:0004540) | 4.01054279 |
| 7 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.69576760 |
| 8 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.69043333 |
| 9 | Myelomeningocele (HP:0002475) | 3.60003726 |
| 10 | Tubulointerstitial nephritis (HP:0001970) | 3.57727966 |
| 11 | Constricted visual fields (HP:0001133) | 3.42887967 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 3.40745206 |
| 13 | Adrenal hypoplasia (HP:0000835) | 3.37189597 |
| 14 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.22162874 |
| 15 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.19046559 |
| 16 | Severe visual impairment (HP:0001141) | 2.90277185 |
| 17 | Partial agenesis of the corpus callosum (HP:0001338) | 2.88130903 |
| 18 | Rhinitis (HP:0012384) | 2.87724958 |
| 19 | Aplasia of the musculature (HP:0100854) | 2.87492997 |
| 20 | Septo-optic dysplasia (HP:0100842) | 2.77814860 |
| 21 | Distal arthrogryposis (HP:0005684) | 2.77643857 |
| 22 | Increased hepatocellular lipid droplets (HP:0006565) | 2.70903343 |
| 23 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.68629965 |
| 24 | Renal cortical cysts (HP:0000803) | 2.63165678 |
| 25 | Concave nail (HP:0001598) | 2.57087608 |
| 26 | Bronchitis (HP:0012387) | 2.54768610 |
| 27 | Absent phalangeal crease (HP:0006109) | 2.51219796 |
| 28 | Choroideremia (HP:0001139) | 2.50381687 |
| 29 | Type II lissencephaly (HP:0007260) | 2.50062632 |
| 30 | Calf muscle hypertrophy (HP:0008981) | 2.49086880 |
| 31 | Increased intramyocellular lipid droplets (HP:0012240) | 2.48980545 |
| 32 | Long nose (HP:0003189) | 2.46532795 |
| 33 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.45853378 |
| 34 | Severe combined immunodeficiency (HP:0004430) | 2.45433589 |
| 35 | Nuclear cataract (HP:0100018) | 2.40230222 |
| 36 | Abnormality of B cell number (HP:0010975) | 2.39772165 |
| 37 | Abnormality of the axillary hair (HP:0100134) | 2.39261516 |
| 38 | Abnormality of secondary sexual hair (HP:0009888) | 2.39261516 |
| 39 | Esophageal atresia (HP:0002032) | 2.38508264 |
| 40 | Abnormal number of incisors (HP:0011064) | 2.38246005 |
| 41 | Slender build (HP:0001533) | 2.34813648 |
| 42 | Anterior segment dysgenesis (HP:0007700) | 2.31536141 |
| 43 | Abnormality of incisor morphology (HP:0011063) | 2.30880256 |
| 44 | Spinal muscular atrophy (HP:0007269) | 2.30760018 |
| 45 | Thyroiditis (HP:0100646) | 2.27255660 |
| 46 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.26078282 |
| 47 | Epidermoid cyst (HP:0200040) | 2.24737948 |
| 48 | Irregular vertebral endplates (HP:0003301) | 2.19506306 |
| 49 | Lipid accumulation in hepatocytes (HP:0006561) | 2.18933102 |
| 50 | Severe muscular hypotonia (HP:0006829) | 2.17052471 |
| 51 | Abnormality of the vertebral endplates (HP:0005106) | 2.16677012 |
| 52 | Renal Fanconi syndrome (HP:0001994) | 2.15905846 |
| 53 | Tubulointerstitial abnormality (HP:0001969) | 2.15401146 |
| 54 | Ulnar claw (HP:0001178) | 2.13681827 |
| 55 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.07564100 |
| 56 | Focal seizures (HP:0007359) | 2.06250373 |
| 57 | Meningocele (HP:0002435) | 2.04705829 |
| 58 | Abnormal finger flexion creases (HP:0006143) | 2.04294253 |
| 59 | Absent thumb (HP:0009777) | 2.02284683 |
| 60 | Poikilocytosis (HP:0004447) | 2.01884445 |
| 61 | Sparse lateral eyebrow (HP:0005338) | 1.98571361 |
| 62 | Respiratory difficulties (HP:0002880) | 1.98516703 |
| 63 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.96470218 |
| 64 | Shawl scrotum (HP:0000049) | 1.96175577 |
| 65 | Paralysis (HP:0003470) | 1.95874988 |
| 66 | Pachygyria (HP:0001302) | 1.92056584 |
| 67 | Poor head control (HP:0002421) | 1.90762788 |
| 68 | Facial hemangioma (HP:0000329) | 1.89021592 |
| 69 | Autoimmune hemolytic anemia (HP:0001890) | 1.88549208 |
| 70 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.88420588 |
| 71 | Hypoplastic pelvis (HP:0008839) | 1.88183041 |
| 72 | Increased muscle lipid content (HP:0009058) | 1.88071160 |
| 73 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.87420645 |
| 74 | Anencephaly (HP:0002323) | 1.85691343 |
| 75 | B lymphocytopenia (HP:0010976) | 1.85546233 |
| 76 | Muscle fiber inclusion bodies (HP:0100299) | 1.82596387 |
| 77 | Cerebral palsy (HP:0100021) | 1.81442142 |
| 78 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.81083447 |
| 79 | Mesangial abnormality (HP:0001966) | 1.80618111 |
| 80 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.80229759 |
| 81 | Erythroderma (HP:0001019) | 1.78944087 |
| 82 | Dialeptic seizures (HP:0011146) | 1.78847344 |
| 83 | Combined immunodeficiency (HP:0005387) | 1.78552831 |
| 84 | Abnormality of renal resorption (HP:0011038) | 1.78474746 |
| 85 | Progressive microcephaly (HP:0000253) | 1.78440514 |
| 86 | Conical tooth (HP:0000698) | 1.75877487 |
| 87 | Decreased subcutaneous fat (HP:0001002) | 1.75369379 |
| 88 | Exertional dyspnea (HP:0002875) | 1.75315130 |
| 89 | Waddling gait (HP:0002515) | 1.74500869 |
| 90 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.74275718 |
| 91 | Pancreatic cysts (HP:0001737) | 1.73593269 |
| 92 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.73442053 |
| 93 | Nemaline bodies (HP:0003798) | 1.71913314 |
| 94 | Glycosuria (HP:0003076) | 1.71747171 |
| 95 | Abnormality of urine glucose concentration (HP:0011016) | 1.71747171 |
| 96 | Absent septum pellucidum (HP:0001331) | 1.70089668 |
| 97 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.69931638 |
| 98 | Difficulty walking (HP:0002355) | 1.69531354 |
| 99 | Cerebellar hypoplasia (HP:0001321) | 1.69303142 |
| 100 | Amniotic constriction ring (HP:0009775) | 1.69046759 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PASK | 3.73562408 |
| 2 | PINK1 | 3.46013354 |
| 3 | BMPR1B | 3.18367248 |
| 4 | MAP3K12 | 3.09843090 |
| 5 | NME1 | 3.00979538 |
| 6 | EPHA4 | 2.88705895 |
| 7 | DYRK2 | 2.83561834 |
| 8 | TAOK3 | 2.69249757 |
| 9 | TGFBR1 | 2.68405597 |
| 10 | ICK | 2.19487092 |
| 11 | MAP3K9 | 2.03181701 |
| 12 | NEK1 | 2.00216509 |
| 13 | GRK1 | 1.95707458 |
| 14 | OBSCN | 1.92623983 |
| 15 | PHKG1 | 1.72445523 |
| 16 | PHKG2 | 1.72445523 |
| 17 | MAP3K11 | 1.68328999 |
| 18 | CDK9 | 1.66819711 |
| 19 | CDK8 | 1.65309664 |
| 20 | ADRBK2 | 1.65293310 |
| 21 | TRPM7 | 1.64617505 |
| 22 | WNK4 | 1.59423897 |
| 23 | PDGFRB | 1.47277375 |
| 24 | ERBB4 | 1.42814647 |
| 25 | MAP4K2 | 1.41336949 |
| 26 | LRRK2 | 1.40947151 |
| 27 | PAK2 | 1.37398800 |
| 28 | MAP2K6 | 1.36834319 |
| 29 | MARK1 | 1.34141294 |
| 30 | MKNK2 | 1.33077678 |
| 31 | MKNK1 | 1.27133333 |
| 32 | MAP2K4 | 1.22735139 |
| 33 | TLK1 | 1.19741442 |
| 34 | CAMK2B | 1.13978119 |
| 35 | SIK2 | 1.11537543 |
| 36 | BRSK2 | 1.08093680 |
| 37 | MAP2K2 | 1.04563970 |
| 38 | GRK6 | 1.01729888 |
| 39 | FLT3 | 1.01270236 |
| 40 | STK39 | 0.98471596 |
| 41 | MAPK13 | 0.98129685 |
| 42 | FRK | 0.91211674 |
| 43 | PRKAA2 | 0.90693695 |
| 44 | BTK | 0.87892589 |
| 45 | ERBB3 | 0.86607226 |
| 46 | DYRK3 | 0.86000732 |
| 47 | ACVR1B | 0.84392428 |
| 48 | CAMK1D | 0.83845817 |
| 49 | PAK3 | 0.78540637 |
| 50 | NEK2 | 0.78237672 |
| 51 | KDR | 0.74030310 |
| 52 | DYRK1A | 0.73449747 |
| 53 | CAMK2A | 0.72667958 |
| 54 | ZAK | 0.72027034 |
| 55 | PKN2 | 0.70529403 |
| 56 | CAMK2G | 0.70497296 |
| 57 | TXK | 0.69720223 |
| 58 | LIMK1 | 0.69706668 |
| 59 | CAMKK1 | 0.68734819 |
| 60 | CAMK1G | 0.68387359 |
| 61 | CAMK2D | 0.66580260 |
| 62 | PRKCZ | 0.65748818 |
| 63 | MAP2K1 | 0.64992738 |
| 64 | ABL2 | 0.63543121 |
| 65 | INSRR | 0.63069475 |
| 66 | KSR1 | 0.63043166 |
| 67 | WNK1 | 0.62711048 |
| 68 | GSK3A | 0.61531539 |
| 69 | PIK3CG | 0.58786756 |
| 70 | CAMKK2 | 0.58194358 |
| 71 | PIM1 | 0.56184921 |
| 72 | CAMK4 | 0.55982678 |
| 73 | ERBB2 | 0.54412586 |
| 74 | CHUK | 0.53933345 |
| 75 | YES1 | 0.53911106 |
| 76 | ABL1 | 0.52822524 |
| 77 | MAPKAPK5 | 0.51974926 |
| 78 | PLK4 | 0.50269499 |
| 79 | ADRBK1 | 0.50246945 |
| 80 | MARK3 | 0.48669962 |
| 81 | SYK | 0.47901741 |
| 82 | PRKCQ | 0.47101913 |
| 83 | MUSK | 0.46754152 |
| 84 | TGFBR2 | 0.45551629 |
| 85 | OXSR1 | 0.44606168 |
| 86 | PNCK | 0.43891131 |
| 87 | IGF1R | 0.42095742 |
| 88 | PRKCE | 0.41920311 |
| 89 | PRKACA | 0.41839591 |
| 90 | CLK1 | 0.36959912 |
| 91 | CSK | 0.35701715 |
| 92 | PRKG1 | 0.35487247 |
| 93 | CDK3 | 0.34885168 |
| 94 | MINK1 | 0.34721727 |
| 95 | TEC | 0.33757949 |
| 96 | PRKCG | 0.33062068 |
| 97 | PRKCH | 0.32757960 |
| 98 | NTRK3 | 0.31170706 |
| 99 | GRK7 | 0.30571330 |
| 100 | MYLK | 0.30301982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Parkinsons disease_Homo sapiens_hsa05012 | 3.92134877 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.15598254 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.05784995 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.03627373 |
| 5 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.77857096 |
| 6 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.45089145 |
| 7 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.38643531 |
| 8 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.29764008 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.15985440 |
| 10 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.10675500 |
| 11 | Alzheimers disease_Homo sapiens_hsa05010 | 1.95577953 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.92697048 |
| 13 | Huntingtons disease_Homo sapiens_hsa05016 | 1.85996289 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.65611219 |
| 15 | Nicotine addiction_Homo sapiens_hsa05033 | 1.65132759 |
| 16 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.59909684 |
| 17 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.59676095 |
| 18 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.56948388 |
| 19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.52918779 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.52135098 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 1.44404573 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.42167236 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.40346039 |
| 24 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.35650181 |
| 25 | Proteasome_Homo sapiens_hsa03050 | 1.32277190 |
| 26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.31631720 |
| 27 | RNA degradation_Homo sapiens_hsa03018 | 1.29485713 |
| 28 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.25812180 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.21072573 |
| 30 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.14761546 |
| 31 | Morphine addiction_Homo sapiens_hsa05032 | 1.14731961 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.11556549 |
| 33 | GABAergic synapse_Homo sapiens_hsa04727 | 1.05617617 |
| 34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.04676935 |
| 35 | ABC transporters_Homo sapiens_hsa02010 | 1.03929820 |
| 36 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.01285100 |
| 37 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.00433075 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.97420087 |
| 39 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.94646608 |
| 40 | Circadian rhythm_Homo sapiens_hsa04710 | 0.93000729 |
| 41 | Malaria_Homo sapiens_hsa05144 | 0.91360406 |
| 42 | Insulin secretion_Homo sapiens_hsa04911 | 0.90857315 |
| 43 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.89211489 |
| 44 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.87595725 |
| 45 | Cocaine addiction_Homo sapiens_hsa05030 | 0.86528556 |
| 46 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.86411769 |
| 47 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.84378896 |
| 48 | Circadian entrainment_Homo sapiens_hsa04713 | 0.82900813 |
| 49 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.81123467 |
| 50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.81051104 |
| 51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.80793102 |
| 52 | Olfactory transduction_Homo sapiens_hsa04740 | 0.79134666 |
| 53 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.78338246 |
| 54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.77196451 |
| 55 | Axon guidance_Homo sapiens_hsa04360 | 0.74381879 |
| 56 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.74088525 |
| 57 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.73222783 |
| 58 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.70105598 |
| 59 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.66327725 |
| 60 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.65569298 |
| 61 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.65390661 |
| 62 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.65369421 |
| 63 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.63317899 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63160629 |
| 65 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.61917949 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60872431 |
| 67 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60031900 |
| 68 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.60019707 |
| 69 | Phototransduction_Homo sapiens_hsa04744 | 0.58624171 |
| 70 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.56258769 |
| 71 | Legionellosis_Homo sapiens_hsa05134 | 0.54432745 |
| 72 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54354203 |
| 73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.53167372 |
| 74 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.52748587 |
| 75 | Spliceosome_Homo sapiens_hsa03040 | 0.51894654 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.51691355 |
| 77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.48648523 |
| 78 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.48509299 |
| 79 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.48426085 |
| 80 | Peroxisome_Homo sapiens_hsa04146 | 0.47877590 |
| 81 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.47106068 |
| 82 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.46335189 |
| 83 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.45788147 |
| 84 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.45261506 |
| 85 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.43454452 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43443166 |
| 87 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.42989747 |
| 88 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.42822602 |
| 89 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.39283980 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.38359373 |
| 91 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.37466465 |
| 92 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.36537134 |
| 93 | Allograft rejection_Homo sapiens_hsa05330 | 0.35442816 |
| 94 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.35004434 |
| 95 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.34647710 |
| 96 | Renin secretion_Homo sapiens_hsa04924 | 0.33999109 |
| 97 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.32949056 |
| 98 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.32783064 |
| 99 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.32193758 |
| 100 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31064873 |

